5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation
Bone · 2026-09 · 210 · 117935
DOI: 10.1016/j.bone.2026.117935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026-09. Verfasst von Maosheng Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Osteoporosis, Signal Transduction. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Shandong Province Department of Science and Technology, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Electronic address: liyivinvent-@outlook.com.
Förderung
- Shandong Province Department of Science and Technology
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yang, M., Yu, Z., Wang, H., Geng, Y., Li, R., Qiao, J., & Li, Y. (2026). 5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation. Bone, 210, 117935. https://doi.org/10.1016/j.bone.2026.117935
Vancouver
Yang M, Yu Z, Wang H, Geng Y, Li R, Qiao J, et al. 5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation. Bone. 2026;210:117935. doi:10.1016/j.bone.2026.117935
BibTeX
@article{Yang2026,
author = {Yang, Maosheng and Yu, Zhiyuan and Wang, Hanbin and Geng, Yitong and Li, Rongrong and Qiao, Jinqiao and Li, Yi},
title = {5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation},
journal = {Bone},
year = {2026},
volume = {210},
pages = {117935},
doi = {10.1016/j.bone.2026.117935}
}
EUVIMED